- call +1-201-465-4211
- email sales@mrinsights.biz
Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children.
Scope of the Report:
This report studies the Acute Spinal Cord Injury market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Spinal Cord Injury market by product type and applications/end industries.
The treatment of acute spinal cord injury is dependent on few factors such as age, health, medical history, severity of spinal cord injury, type of spinal cord injury and extent of psychological recovery. The treatment regime of acute spinal cord injury consists of medical management and observation in intensive care unit (ICU), corticosteroids to decrease the swelling, mechanical ventilator, bladder catheter and feeding tube. The treatments available against acute spinal cord injury are anterior cervical discectomy (ACDF), total disc arthroplasty, cervical laminoplasty, posterior aminotomy microdiscectomy, lumbar decompression, lumbar fusion and kyphoplasty.
North America was observed to be the largest market for acute spinal cord injury (SCI) diagnosis and treatment. Increasing awareness and advanced technologies are the major driving factors of this market. Europe was observed to be the second largest market as the region is one of the leading research destinations for neurological diseases diagnosis and treatment. Asia-Pacific and Rest of the World were observed to be the most potential markets for acute spinal cord injuries diagnosis and treatment market.
The global Acute Spinal Cord Injury market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acute Spinal Cord Injury.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Novartis
Oxygen Biotherapeutics
BioAxone BioSciences
AOSpine International
Neuronax
K-Stemcell
Asterias Biotherapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laboratory Tests
Imaging Tests
Market Segment by Applications, can be divided into
Hospitals
Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Acute Spinal Cord Injury Market Overview
1.1 Product Overview and Scope of Acute Spinal Cord Injury
1.2 Classification of Acute Spinal Cord Injury by Types
1.2.1 Global Acute Spinal Cord Injury Revenue Comparison by Types (2017-2023)
1.2.2 Global Acute Spinal Cord Injury Revenue Market Share by Types in 2017
1.2.3 Laboratory Tests
1.2.4 Imaging Tests
1.3 Global Acute Spinal Cord Injury Market by Application
1.3.1 Global Acute Spinal Cord Injury Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Acute Spinal Cord Injury Market by Regions
1.4.1 Global Acute Spinal Cord Injury Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Acute Spinal Cord Injury Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Spinal Cord Injury Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Spinal Cord Injury Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Acute Spinal Cord Injury Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Spinal Cord Injury Status and Prospect (2013-2023)
1.5 Global Market Size of Acute Spinal Cord Injury (2013-2023)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Acute Spinal Cord Injury Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oxygen Biotherapeutics
2.2.1 Business Overview
2.2.2 Acute Spinal Cord Injury Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Oxygen Biotherapeutics Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioAxone BioSciences
2.3.1 Business Overview
2.3.2 Acute Spinal Cord Injury Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioAxone BioSciences Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.4 AOSpine International
2.4.1 Business Overview
2.4.2 Acute Spinal Cord Injury Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AOSpine International Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.5 Neuronax
2.5.1 Business Overview
2.5.2 Acute Spinal Cord Injury Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Neuronax Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.6 K-Stemcell
2.6.1 Business Overview
2.6.2 Acute Spinal Cord Injury Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 K-Stemcell Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
2.7 Asterias Biotherapeutics
2.7.1 Business Overview
2.7.2 Acute Spinal Cord Injury Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Asterias Biotherapeutics Acute Spinal Cord Injury Revenue, Gross Margin and Market Share (2016-2017)
3 Global Acute Spinal Cord Injury Market Competition, by Players
3.1 Global Acute Spinal Cord Injury Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Spinal Cord Injury Players Market Share
3.2.2 Top 10 Acute Spinal Cord Injury Players Market Share
3.3 Market Competition Trend
4 Global Acute Spinal Cord Injury Market Size by Regions
4.1 Global Acute Spinal Cord Injury Revenue and Market Share by Regions
4.2 North America Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
4.3 Europe Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
4.5 South America Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
5 North America Acute Spinal Cord Injury Revenue by Countries
5.1 North America Acute Spinal Cord Injury Revenue by Countries (2013-2018)
5.2 USA Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
5.3 Canada Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
5.4 Mexico Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
6 Europe Acute Spinal Cord Injury Revenue by Countries
6.1 Europe Acute Spinal Cord Injury Revenue by Countries (2013-2018)
6.2 Germany Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
6.3 UK Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
6.4 France Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
6.5 Russia Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
6.6 Italy Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Acute Spinal Cord Injury Revenue by Countries
7.1 Asia-Pacific Acute Spinal Cord Injury Revenue by Countries (2013-2018)
7.2 China Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
7.3 Japan Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
7.4 Korea Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
7.5 India Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
8 South America Acute Spinal Cord Injury Revenue by Countries
8.1 South America Acute Spinal Cord Injury Revenue by Countries (2013-2018)
8.2 Brazil Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
8.3 Argentina Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
8.4 Colombia Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Acute Spinal Cord Injury by Countries
9.1 Middle East and Africa Acute Spinal Cord Injury Revenue by Countries (2013-2018)
9.2 Saudi Arabia Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
9.3 UAE Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
9.4 Egypt Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
9.5 Nigeria Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
9.6 South Africa Acute Spinal Cord Injury Revenue and Growth Rate (2013-2018)
10 Global Acute Spinal Cord Injury Market Segment by Type
10.1 Global Acute Spinal Cord Injury Revenue and Market Share by Type (2013-2018)
10.2 Global Acute Spinal Cord Injury Market Forecast by Type (2018-2023)
10.3 Laboratory Tests Revenue Growth Rate (2013-2023)
10.4 Imaging Tests Revenue Growth Rate (2013-2023)
11 Global Acute Spinal Cord Injury Market Segment by Application
11.1 Global Acute Spinal Cord Injury Revenue Market Share by Application (2013-2018)
11.2 Acute Spinal Cord Injury Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Acute Spinal Cord Injury Market Size Forecast (2018-2023)
12.1 Global Acute Spinal Cord Injury Market Size Forecast (2018-2023)
12.2 Global Acute Spinal Cord Injury Market Forecast by Regions (2018-2023)
12.3 North America Acute Spinal Cord Injury Revenue Market Forecast (2018-2023)
12.4 Europe Acute Spinal Cord Injury Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Acute Spinal Cord Injury Revenue Market Forecast (2018-2023)
12.6 South America Acute Spinal Cord Injury Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Acute Spinal Cord Injury Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Acute Spinal Cord Injury Picture
Table Product Specifications of Acute Spinal Cord Injury
Table Global Acute Spinal Cord Injury and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
